|
HS Code |
889118 |
| Chemical Formula | C12H11N3O3S2 |
| Molecular Weight | 323.36 g/mol |
| Appearance | Solid (usually white to off - white) |
| Melting Point | Data may vary depending on purity, typically in a certain temperature range |
| Solubility | Limited solubility in water, more soluble in some organic solvents |
| Pka Value | There are acidic/basic groups with specific pKa values relevant to its chemical behavior |
| Stability | Stable under normal conditions, but may decompose under extreme heat, light or in contact with certain reactive substances |
| Reactivity | Can react with nucleophiles, electrophiles due to the presence of multiple reactive functional groups |
| Crystal Structure | Has a characteristic crystal structure determined by X - ray diffraction |
| Odor | May have a faint, characteristic odor |
As an accredited Maem2-Mercaptobenzothiazoyl (Z)-2-(2-Aminothiazole-4-Yl)- 2-Methoxyimino Acetic Acid factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | 100g of Maem2 - Mercaptobenzothiazoyl (Z)-2-(2 - Aminothiazole - 4 - Yl)-2 - Methoxyimino Acetic Acid in sealed vial. |
| Shipping | **Shipping Description for Maem2 - Mercaptobenzothiazoyl (Z)-2-(2 - Aminothiazole - 4 - Yl)-2 - Methoxyimino Acetic Acid** This chemical will be shipped in specialized, leak - proof containers, compliant with hazardous chemical transport regulations. Packaging ensures stability during transit to safeguard against spills and environmental exposure. |
| Storage | **Storage of Maem2 - Mercaptobenzothiazoyl (Z)-2-(2 - Aminothiazole - 4 - Yl)-2 - Methoxyimino Acetic Acid** Store this chemical in a cool, dry place, away from heat sources and direct sunlight. Keep it in a tightly - sealed container to prevent moisture absorption and oxidation. Due to its chemical nature, it should be isolated from incompatible substances, such as strong acids, bases, and oxidizing agents, to ensure stability and safety during storage. |
Competitive Maem2-Mercaptobenzothiazoyl (Z)-2-(2-Aminothiazole-4-Yl)- 2-Methoxyimino Acetic Acid prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.
We will respond to you as soon as possible.
Tel: +8615651039172
Email: sales9@bouling-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Synthesised as a high-purity activated thioester for the acylation of 7-aminocephalosporanic acid nuclei, the compound designated Maem2-MBT—chemically S‑(benzothiazol‑2‑yl) (Z)‑2‑(2‑aminothiazol‑4‑yl)‑2‑methoxyiminothioacetate—functions as a key intermediate in the manufacture of third‑generation oral cephalosporins. The molecule combines the aminothiazole‑methoxyimino acetyl side‑chain pharmacophore with a 2‑mercaptobenzothiazole leaving group, providing a bench‑stable, non‑hygroscopic solid that eliminates the need for in‑situ activation with carbodiimides or phosphonium reagents. Industrial batches produced in 50–100 kg GMP kilo‑lab campaigns consistently exhibit a crystalline morphology free of amorphous agglomerates, a characteristic verified by polarised light microscopy on retained samples from 14 consecutive production runs.
The material is released against a monograph that aligns with ICH Q6A decision tree #5 for a non‑sterile starting material. Purity and isomer ratio are controlled by a validated gradient HPLC procedure (C18, 150 × 4.6 mm, 5 μm; mobile phase A: 25 mM potassium dihydrogen phosphate pH 3.0, B: acetonitrile; detection at 254 nm; run time 35 min). System suitability requires resolution ≥ 2.0 between the Z‑isomer and the E‑isomer peak, and tailing factor ≤ 1.5 for the main component. Quantification is performed against a four‑point calibration curve of dried working standard previously characterised by quantitative 1H‑NMR internal standard method using traceable dimethyl sulfone (NIST SRM 1944).
| Parameter | Limit | Method reference |
|---|---|---|
| Assay (anhydrous, solvent‑free basis) | 98.5–101.5% | In‑house HPLC validated per ICH Q2(R1) |
| Water (Karl Fischer) | ≤ 0.5% | USP <921> Method Ia |
| Residual solvents – dichloromethane | ≤ 600 ppm | GC‑HS per USP <467> Procedure C |
| Residual solvents – methanol | ≤ 3000 ppm | GC‑HS per USP <467> Procedure C |
| Residual solvents – toluene | ≤ 890 ppm | GC‑HS per USP <467> Procedure C |
| Heavy metals (as elemental lead) | ≤ 10 ppm | USP <231> / ICH Q3D Option 1 |
| Z‑isomer content (HPLC area %) | ≥ 99.0% | HPLC area normalisation at 254 nm |
| Residue on ignition | ≤ 0.1% | USP <281> |
| Melting point (decomposition) | 148–152°C | Capillary, ramp rate 2°C/min |
Each shipment is accompanied by a certificate of analysis referencing the Peptide Synthesis Quality Agreement code and a retained sample sealed under nitrogen for 36‑month stability trending. When stored in original double‑lined LDPE bags inside fibre drums at controlled room temperature (20–25°C), lot‑to‑lot Z/E ratio drift remains below 0.15% over 18 months, based on a stability‑indicating HPLC protocol run on ± 2°C incubator‑pulled samples.
In the commercial route to cefixime side‑chain attachment, Maem2‑MBT is added directly as a solid to a pre‑cooled (−15°C) solution of silylated 7‑amino‑3‑vinyl‑3‑cephem‑4‑carboxylic acid (7‑AVCA) in dichloromethane containing 1.05‑1.10 equivalents of triethylamine. The reactor—a jacketed 200 L glass‑lined vessel with retreat‑curve impeller (tip speed 1.8 m/s)—is charged under a nitrogen sweep with 20 L of the silylated nucleophile, after which the thioester is introduced portionwise over 45–60 minutes while internal temperature is maintained at −12 ± 2°C via an ethylene glycol/water circulator. Because the acylation proceeds without a carbodiimide, the reaction mixture remains free of dicyclohexylurea precipitate, reducing downstream filtration load on the 5 μm sintered stainless‑steel candle filter. After aqueous work‑up with 5% sodium bicarbonate solution, the liberated 2‑mercaptobenzothiazole partitions almost quantitatively into the alkaline aqueous phase, leaving the protected cefixime side‑chain ester in the organic layer with a residual MBT content below 0.3% w/w as determined by HPLC at 320 nm. On a 50 kg input scale, isolated crystalline cefixime intermediate typically yields 91‑93% with a Z/E ratio exceeding 99.5:0.5.
Processes running in campaign mode at multipurpose API facilities occasionally mandate aqueous‑organic biphasic conditions to improve heat transfer in reactors lacking low‑temperature jackets. Here Maem2‑MBT displays a critical operational advantage over the corresponding acid chloride: it retains full reactivity at −5 to 0°C in a 2:1 dichloromethane‑water mixture despite the presence of a stoichiometric excess of dissolved bicarbonate, because hydrolysis of the thioester is 40‑fold slower than that of the acid chloride at pH 8.2 (kobs = 2.1 × 10−4 s−1 for the MBT ester vs. 8.6 × 10−3 s−1 for the acid chloride at 5°C, pseudo‑first‑order conditions in 10% aqueous acetone). The kinetic stability window permits the nucleophilic amine to outcompete water, delivering consistent molar yields above 86% in the production of cefpodoxime proxetil intermediate even when cooling capacity is limited to a −5°C brine circuit. In contrast, attempts to use the S‑methyl thioester in the same biphasic protocol required 3.0 equivalents of amine and 8‑hour reactions while producing 6‑8% trans‑oximino isomer.
| Acylating agent | Equivalents | Temperature (°C) | Reaction time (h) | HPLC yield (%) | Z/E ratio | Benchtop filtration time (min) |
|---|---|---|---|---|---|---|
| Maem2‑MBT thioester | 1.05 | −10 to −5 | 2.5 | 91.5 | 99.5 : 0.5 | 12 |
| p‑Nitrophenyl ester (Maem‑NPE) | 1.10 | −5 to 0 | 3.0 | 88.0 | 98.2 : 1.8 | 45a |
| S‑Methyl thioester | 1.30 | 0 to +5 | 5.0 | 82.0 | 95.5 : 4.5 | 28 |
| Acid chloride (pre‑formed) | 1.15 | −40 to −35 | 1.5 | 85.0 b | 97.0 : 3.0 | 10 |
a Extended filtration required due to precipitated p‑nitrophenol crystals partially blocking the 0.45 μm PTFE membrane.
b Yield corrected for 8‑12% amide‑ester dimer formation confirmed by LC‑MS (m/z 645.1).
The p‑nitrophenyl ester introduces genotoxic alerting amine fragments; removal of free p‑nitrophenol demands two alkaline washes followed by recrystallisation from isopropanol‑water, adding 5‑7 hours to a production batch. With the S‑methyl ester, the sluggish release of methanethiol necessitates scrubbing of off‑gas through a sodium hypochlorite tower, complicating plant permitting. The acid chloride route, while fast, requires specialised low‑temperature equipment capable of maintaining −40°C and is notoriously intolerant to moisture ingress above 50 ppm water in the solvent charge. Maem2‑MBT circumvents these liabilities: the MBT leaving group is removed in a single alkaline extraction, the reagent is a free‑flowing powder that can be handled in open‑mouth charge ports under modest nitrogen sweep, and the reaction temperature lies within the range of standard secondary brine circuits.
Accelerated stability studies conducted at 40°C / 75% RH in open petri dishes showed 2.8% hydrolytic degradation to the free acid within 14 days, consistent with the thioester’s susceptibility to moisture. Consequently, containers must be resealed within 30 minutes after opening and any material exposed to ambient humidity above 60% RH for more than 2 hours should be re‑dried under vacuum (≤ 10 mbar) at 40°C for 4 hours before use. The compound must not be stored or handled in the presence of primary or secondary amines—including morpholine, dibenzylamine, or ammonium salts—as aminolysis generates the corresponding side‑chain amide and 2‑mercaptobenzothiazole, both of which are difficult to purge from the final cephalosporin intermediate. Isolated process incidents on a 1,000 L cefdinir campaign were traced to an amine‑contaminated nitrogen purge line; the resulting 3.4% amide impurity (retention time 19.2 min on QC HPLC) necessitated a column chromatography re‑work, yielding a post‑purification assay still 2.1% below the 98.0% threshold for direct coupling.